Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001428176 | SCV001630869 | likely benign | Spastic paraplegia | 2023-12-15 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000867169 | SCV001879557 | uncertain significance | not provided | 2020-10-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987728 | SCV004804310 | likely benign | not specified | 2024-01-09 | criteria provided, single submitter | clinical testing | Variant summary: L1CAM c.367G>A (p.Ala123Thr) results in a non-conservative amino acid change located in the Immunoglobulin subtype domain (IPR003599) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 1206577 control chromosomes, including 14 hemizygotes. This frequency is not significantly higher than estimated for a pathogenic variant in L1CAM causing L1 Syndrome (3.2e-05 vs 0.0065), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.367G>A in individuals affected with L1 Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 699379). Based on the evidence outlined above, the variant was classified as as likely benign. |